Ophthalmology Times Newsletter

To view this email as a web page, click here.

Researchers find long-term statin use linked to lower POAG risk

A study suggests that patients who used statins for five years or more had a 21% lower chance of primary open-angle glaucoma.

Learn more

Facing challenge of corneal infection management in operated eyes

Corneal infections involving surgical interfaces and incisions represent high-stakes situations. Bennie H. Jeng, MD, MS, discusses diagnosis and management of these challenging situations.

Find out more

Pearls for managing care of high-risk uveal melanoma patients

When it comes to adjuvant treatment for high-risk uveal melanoma, physicians are turning to sunitinib malate (Sutent, Pfizer)—an oral multi-targeted tyrosine kinase inhibitor with anti-tumor and immune modulating effect—as a viable option, according to Carol L. Shields, MD, chief of ocular oncology service at Wills Eye Hospital, Philadelphia.

Learn more

Ophthalmology can ‘adopt’ technologies from other specialties

Controlling adult glaucoma with cataract surgery, stent

New IOL design trends avoid negative dysphotopsias

Examining comparable surgical methods for IOL dislocation

Intraoperative surgical methods key to AMD treatment

Treating dry eye with recombinant human nerve growth factor

Gene therapy for LHON: Deciphering phase III data

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.